↓ Skip to main content

Pulmonary Dysfunction and Disease

Overview of attention for book
Attention for Chapter 21: Pertussis: History of the Disease and Current Prevention Failure
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Pertussis: History of the Disease and Current Prevention Failure
Chapter number 21
Book title
Pulmonary Dysfunction and Disease
Published in
Advances in experimental medicine and biology, June 2016
DOI 10.1007/5584_2016_21
Pubmed ID
Book ISBNs
978-3-31-942009-7, 978-3-31-942010-3
Authors

Kuchar, E., Karlikowska-Skwarnik, M., Han, S., Nitsch-Osuch, A., E. Kuchar, M. Karlikowska-Skwarnik, S. Han, A. Nitsch-Osuch

Abstract

Pertussis or whooping cough has been given many names over the centuries. It was first recognized in the Middle Ages and since then various epidemics have been described. Jules Bordet and Octave Gengou isolated Bordetella pertussis, a causative agent for whooping cough, in Paris more than 100 years ago, which created an excellent opportunity to invent a vaccine. In 1914 the whole-cell pertussis vaccine was invented, then in the 1940s it was combined with tetanus and diphtheria toxoids to become DTP and it became widely available. A successive decrease in the incidence of the disease has since been observed. The vaccine has been about 80 % effective in preventing serious disease and death from pertussis. The disadvantage is that the vaccine offers protection for 5-10 years after the last dose of the full vaccination course. The second issue is the question of how to prevent side effects of the whole-cell vaccine. In the 1990s, the acellular vaccine was introduced in the US and gradually replaced the whole-cell vaccine. About 10 years later, a possible failure with the new vaccine has been observed, that is a lack of long-term protection. Nowadays, both vaccines are used, with the acellular vaccine being vastly predominant in most developed countries. Pertussis incidence has increased since the 1980s, but new prevention strategies include booster doses for specific age groups.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 23%
Student > Master 7 18%
Researcher 6 15%
Professor 3 8%
Student > Doctoral Student 3 8%
Other 7 18%
Unknown 5 13%
Readers by discipline Count As %
Medicine and Dentistry 12 30%
Biochemistry, Genetics and Molecular Biology 8 20%
Nursing and Health Professions 6 15%
Agricultural and Biological Sciences 4 10%
Immunology and Microbiology 4 10%
Other 2 5%
Unknown 4 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2019.
All research outputs
#4,667,085
of 15,423,946 outputs
Outputs from Advances in experimental medicine and biology
#674
of 3,525 outputs
Outputs of similar age
#118,953
of 356,547 outputs
Outputs of similar age from Advances in experimental medicine and biology
#114
of 643 outputs
Altmetric has tracked 15,423,946 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,525 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,547 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 643 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.